Evaluation of AAV-DJ vector for retinal gene therapy
Purpose The most common virus vector used in gene therapy research for ophthalmologic diseases is the adeno-associated virus (AAV) vector, which has been used successfully in a number of preclinical and clinical studies. It is important to evaluate novel AAV vectors in animal models for application...
Main Authors: | Yusaku Katada, Kenta Kobayashi, Kazuo Tsubota, Toshihide Kurihara |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/6317.pdf |
Similar Items
-
Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency
by: Mathieu Mével, et al.
Published: (2024-03-01) -
Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2020-06-01) -
Immunological responses to retinal gene therapy
by: Chandler, L
Published: (2021) -
Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies
by: Xue Xia, et al.
Published: (2023-12-01) -
AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy
by: Ridhwaanah Jacobs, et al.
Published: (2023-12-01)